Oncolytics Biotech, Inc. (ONCY)
Nasdaq: ONCY · Pharmaceutical Preparations · Calgary · filing with the SEC since 2002
Filings
493 filings since 2017 beside 40 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 6, 2026.
Filings a yearinsider forms included
40453547344360129
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Jul 24, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jul 8, 2026.Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Jun 2, 2026.SEC letters: 5 in the last 36 months, the newest Apr 1, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
40 of 493 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.